Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,301 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Differences in pharmacokinetics and pharmacodynamics of colistimethate sodium (CMS) and colistin between three different CMS dosage regimens in a critically ill patient infected by a multidrug-resistant Acinetobacter baumannii.
Luque S, Grau S, Valle M, Sorlí L, Horcajada JP, Segura C, Alvarez-Lerma F. Luque S, et al. Among authors: valle m. Int J Antimicrob Agents. 2013 Aug;42(2):178-81. doi: 10.1016/j.ijantimicag.2013.04.018. Epub 2013 Jun 14. Int J Antimicrob Agents. 2013. PMID: 23769664
Reduced darunavir dose is as effective in maintaining HIV suppression as the standard dose in virologically suppressed HIV-infected patients: a randomized clinical trial.
Moltó J, Valle M, Ferrer E, Domingo P, Curran A, Santos JR, Mateo MG, Di Yacovo MS, Miranda C, Podzamczer D, Clotet B; DRV600 Study Group. Moltó J, et al. Among authors: valle m. J Antimicrob Chemother. 2015 Apr;70(4):1139-45. doi: 10.1093/jac/dku516. Epub 2014 Dec 18. J Antimicrob Chemother. 2015. PMID: 25525195 Clinical Trial.
Plasma and intracellular (peripheral blood mononuclear cells) pharmacokinetics of once-daily raltegravir (800 milligrams) in HIV-infected patients.
Moltó J, Valle M, Back D, Cedeño S, Watson V, Liptrott N, Egan D, Miranda C, Barbanoj MJ, Clotet B. Moltó J, et al. Among authors: valle m. Antimicrob Agents Chemother. 2011 Jan;55(1):72-5. doi: 10.1128/AAC.00789-10. Epub 2010 Oct 11. Antimicrob Agents Chemother. 2011. PMID: 20937791 Free PMC article. Clinical Trial.
Darunavir inhibitory quotient predicts the 48-week virological response to darunavir-based salvage therapy in human immunodeficiency virus-infected protease inhibitor-experienced patients.
Moltó J, Santos JR, Pérez-Alvarez N, Cedeño S, Miranda C, Khoo S, Else L, Llibre JM, Valle M, Clotet B. Moltó J, et al. Among authors: valle m. Antimicrob Agents Chemother. 2008 Nov;52(11):3928-32. doi: 10.1128/AAC.00520-08. Epub 2008 Aug 25. Antimicrob Agents Chemother. 2008. PMID: 18725446 Free PMC article.
1,301 results